`Sent:
`To:
`Subject:
`Attachments:
`
`Krumplitsch, Susan
`Wednesday, January 17, 2018 2:53 PM
`Mao,Philip
`FW:VimovoCaseII- Mylan's Counterclaims on the ‘698 Patent
`Stipulation to Dismiss Case II 698 patent Counterclaims_Mylan REDLINEto....docx
`
`From: Swanson,Robert D. (Perkins Coie) [mailto:RSwanson@perkinscoie.com]
`Sent: Wednesday, February 15, 2017 8:45 AM
`To: Pfifferling, Danielle <Danielle.Pfifferling@finnegan.com>; Artiles, Guillermo <gartiles@mccarter.com>; DNJ Litigation
`- JEF <HW@McCcCarter.com>; Scordino, Ellen <escordino@cooley.com>;jeff.gritton@bakerbotts.com; Monroe, James
`<james.monroe@finnegan.com>; stephen.hash@bakerbotts.com; Krumplitsch, Susan <skrumplitsch@cooley.com>;
`Roorda, Jeanette <Jeanette.Roorda@finnegan.com>; shannon.kidd@bakerbotts.com
`Cc: Gregory.Miller@rivkin.com; Nancy.Delpizzo@rivkin.com; Gene.Kang@rivkin.com; EsoNaproxen@perkinscoie.com
`Subject: RE: Vimovo Case II- Mylan's Counterclaims on the '698 Patent
`
`Danielle,
`
`Please see the attached redline of our edits to your redline. Our understanding of the local rules and the scheduling
`orders in both casesis that we were required to serve ourinvalidity contentions on the 698 patent on April 15, 2016 in
`CaseIl and February 14, 2017 in CaseIll, which is what we have done. Please notify Mylan by COB tomorrow whether
`Plaintiffs will oppose the stipulation, and if so, on what basis.
`If Plaintiffs disagree with our understandingof the local rules
`and the scheduling orders, we intend to let the Court know thatPlaintiffs oppose dismissal of the counterclaimsat issue
`without prejudice (and thus opposelitigation of the claims in the mostefficient manner, and in the casesPlaintiffs chose to
`litigate them), on the basis that Mylan complied with the scheduling order and local patentrules in CaseIll.
`
`Best,
`Rob
`
`Robert Swanson| Perkins Coie LLP
`ASSOCIATE*
`700 Thirteenth Street, N.W. Suite 600
`Washington, DC 20005-3960
`D. +1.202.654.1729
`F. +1.202.654.9507
`E. RSwanson@perkinscoie.com
`
`* Admitted onlyin California
`** Admission to DC pending
`
`From: Pfifferling, Danielle [mailto: Danielle. Pfifferling@finnegan.com]
`Sent: Tuesday, February 14, 2017 5:30 PM
`To: Swanson, Robert D. (WDC); Artiles, Guillermo; DNJ Litigation - JEF; 'Scordino, Ellen’; jeff.gritton@bakerbotts.com;
`Monroe, James; stephen.hash@bakerbotts.com; Krumplitsch, Susan; Roorda, Jeanette; shannon.kidd@bakerbotts.com
`Cc: Gregory.Miller@rivkin.com; Nancy.Delpizzo@rivkin.com; Gene.Kang@rivkin.com; *Eso-Naproxen
`Subject: RE: Vimovo Case II- Mylan's Counterclaims on the '698 Patent
`
`Dear Rob,
`
`Attachedis a redlined version of the draft stipulation for Mylan’s consideration.
`
`Kind Regards,
`
`Page 1 of 3
`
`Patent Owner Ex. 2010
`Mylan v. Pozen
`IPR2017-01995
`
`Page 1 of 3
`
`Patent Owner Ex. 2010
`Mylan v. Pozen
`IPR2017-01995
`
`
`
`Danielle
`
`Danielle C. Pfifferling
`Attorney at Law
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW, Washington, DC 20001-4413
`+1 202 408 4434 | fax +1 202 408 4400 | danielle.pfifferling@finnegan.com | www.finnegan.com
`
`
`
`
`
`
`From: Swanson, Robert D. (Perkins Coie) [mailto:RSwanson@perkinscoie.com]
`Sent: Monday, February 13, 2017 12:16 PM
`To: Artiles, Guillermo; DNJ Litigation - JEF; Pfifferling, Danielle; 'Scordino, Ellen'; jeff.gritton@bakerbotts.com; Monroe,
`James; stephen.hash@bakerbotts.com; Krumplitsch, Susan; Roorda, Jeanette; shannon.kidd@bakerbotts.com
`Cc: Gregory.Miller@rivkin.com; Nancy.Delpizzo@rivkin.com; Gene.Kang@rivkin.com; EsoNaproxen@perkinscoie.com
`Subject: RE: Vimovo Case II- Mylan's Counterclaims on the '698 Patent
`
`Counsel, Mylan would also appreciate a response on the draft stipulation we circulated a week ago.
`
`Thanks,
`Rob
`
`Robert Swanson | Perkins Coie LLP
`ASSOCIATE*
`700 Thirteenth Street, N.W. Suite 600
`Washington, DC 20005-3960
`D. +1.202.654.1729
`F. +1.202.654.9507
`E. RSwanson@perkinscoie.com
`
` *
`
` Admitted only in California
`** Admission to DC pending
`
`From: Swanson, Robert D. (WDC)
`Sent: Friday, February 10, 2017 11:36 AM
`To: 'Artiles, Guillermo'; 'DNJ Litigation - JEF'; 'Pfifferling, Danielle'; 'Scordino, Ellen'; 'jeff.gritton@bakerbotts.com';
`'Monroe, James'; 'stephen.hash@bakerbotts.com'; 'Krumplitsch, Susan'; 'Roorda, Jeanette';
`'shannon.kidd@bakerbotts.com'
`Cc: 'Gregory.Miller@rivkin.com'; 'Nancy.Delpizzo@rivkin.com'; 'Gene.Kang@rivkin.com'; *Eso-Naproxen
`Subject: RE: Vimovo Case II- Mylan's Counterclaims on the '698 Patent
`
`Counsel,
`
`Do Plaintiffs object to Mylan’s draft stipulation? Please let us know as soon as possible, and if so, please provide times
`Plaintiffs are available to meet and confer.
`
`Thanks,
`Rob
`
`Robert Swanson | Perkins Coie LLP
`ASSOCIATE*
`700 Thirteenth Street, N.W. Suite 600
`Washington, DC 20005-3960
`D. +1.202.654.1729
`F. +1.202.654.9507
`E. RSwanson@perkinscoie.com
`
`2
`
` *
`
` Admitted only in California
`** Admission to DC pending
`
`Page 2 of 3
`
`Patent Owner Ex. 2010
`Mylan v. Pozen
`IPR2017-01995
`
`
`
`
`From: Swanson, Robert D. (WDC)
`Sent: Monday, February 06, 2017 8:05 AM
`To: 'Artiles, Guillermo'; DNJ Litigation - JEF; 'Pfifferling, Danielle'; 'Scordino, Ellen'; jeff.gritton@bakerbotts.com; Monroe,
`James; stephen.hash@bakerbotts.com; Krumplitsch, Susan; Roorda, Jeanette; shannon.kidd@bakerbotts.com
`Cc: Gregory.Miller@rivkin.com; Nancy.Delpizzo@rivkin.com; Gene.Kang@rivkin.com; *Eso-Naproxen
`Subject: Vimovo Case II- Mylan's Counterclaims on the '698 Patent
`
`Counsel,
`
`As you are aware, Mylan filed counterclaims related to the ’698 patent in Vimovo case II. However, given that Plaintiffs
`asserted the ’698 patent and the related ’208 patent against Mylan in the Vimovo III case, it would be more efficient for the
`parties and the court to litigate those patents together in the Vimovo III case. To that end, we have attached a draft
`stipulation to dismiss Mylan's counterclaim in case II. Please let us know by COB Wednesday if Plaintiffs agree.
`
`Best,
`Rob
`
`Robert Swanson | Perkins Coie LLP
`ASSOCIATE*
`700 Thirteenth Street, N.W. Suite 600
`Washington, DC 20005-3960
`D. +1.202.654.1729
`F. +1.202.654.9507
`E. RSwanson@perkinscoie.com
`
` *
`
` Admitted only in California
`** Admission to DC pending
`
`
`
`NOTICE: This communication may contain privileged or other confidential information. If you have received it in error, please advise the sender by reply email and
`immediately delete the message and any attachments without copying or disclosing the contents. Thank you.
`
`
`This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged, confidential, proprietary, or otherwise
`exempt from disclosure under applicable law. If you believe you have received this message in error, please advise the sender by return e-mail and delete it from
`your mailbox. Thank you.
`
`
`
`NOTICE: This communication may contain privileged or other confidential information. If you have received it in error, please advise the sender by reply email and
`immediately delete the message and any attachments without copying or disclosing the contents. Thank you.
`
`3
`
`Page 3 of 3
`
`Patent Owner Ex. 2010
`Mylan v. Pozen
`IPR2017-01995
`
`